Blockchain-Based Supply Chain Systems, Interoperability Model in a Pharmaceutical Case Study

Yeray Mezquita*, Blaz Podgorelec, Ana Belen Gil-Gonzalez, Juan Manuel Corchado

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

The main purpose of supply chain systems based on blockchain technology is to take advantage of technology innovations to ensure that a tracked asset's audit trail is immutable. However, the challenge lies in tracking the asset among different blockchain-based supply chain systems. The model proposed in this paper has been designed to overcome the identified challenges. Specifically, the proposed model enables: (1) the asset to be tracked among different blockchain-based supply-chain systems; (2) the tracked asset’s supply chain to be cryptographically verified; (3) a tracked asset to be defined in a standardized format; and (4) a tracked asset to be described with several different standardized formats. Thus, the model provides a great advantage in terms of interoperability between different blockchain-driven supply chains over other models in the literature, which will need to replicate the information in each blockchain platform they operate with, while giving flexibility to the platforms that make use of it and maintain the scalability of those logistic platforms. This work aims to examine the application of the proposed model from an operational point of view, in a scenario within the pharmaceutical sector.
Original languageEnglish
Article number1962
JournalSensors
Volume23
Issue number4
DOIs
Publication statusPublished - 9 Feb 2023

Keywords

  • Blockchain
  • verifiable credentials
  • supply chain
  • traceability
  • interoperability
  • blockchain

ASJC Scopus subject areas

  • Analytical Chemistry
  • Information Systems
  • Instrumentation
  • Atomic and Molecular Physics, and Optics
  • Electrical and Electronic Engineering
  • Biochemistry

Fingerprint

Dive into the research topics of 'Blockchain-Based Supply Chain Systems, Interoperability Model in a Pharmaceutical Case Study'. Together they form a unique fingerprint.

Cite this